In silco studies on modified hydroxamic acid and valporic acid as potential inhibitors for HDAC2

• Հիմնական հեղինակներ: Naresh Kandakatla (Հեղինակ), Shikha Rathaur (Հեղինակ), Smruti Sandhya Sahoo (Հեղինակ), Geetha Ramakrishnan (Հեղինակ)
• Ձևաչափ: Գիրք
• Հրապարակվել է: Bangladesh Pharmacological Society, 2013-08-01T00:00:00Z.
• Խորագրեր: article
• Առցանց հասանելիություն: Connect to this object online.

Histone deacetylases2, Class 1 HDAC family are emerged as an important therapeutic target for the treatment of various cancers. HDAC2 inhibitors are potent anti-cancer agents. Two inhibitors of HDAC2 are Hydroxamic acid and Valporic acid which are potent inducers of growth arrest, differentiation, a...